EP Patent

EP1837016A2 — Pharmaceutical multiple-unit composition

Assigned to KRKA dd · Expires 2007-09-26 · 19y expired

What this patent protects

The invention relates to pharmaceutical multiple-unit compositions which comprise active ingredient-containing units and protective granules comprising in particular microcrystalline cellulose and polyethylene glycol and which compositions show improved resistance against mechani…

USPTO Abstract

The invention relates to pharmaceutical multiple-unit compositions which comprise active ingredient-containing units and protective granules comprising in particular microcrystalline cellulose and polyethylene glycol and which compositions show improved resistance against mechanical damages during compression processes.

Drugs covered by this patent

Patent Metadata

Patent number
EP1837016A2
Jurisdiction
EP
Classification
—
Expires
2007-09-26
Drug substance claim
No
Drug product claim
No
Assignee
KRKA dd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.